Serina Therapeutics (SER) Other Non-Current Assets (2017 - 2026)

Serina Therapeutics has disclosed Other Non-Current Assets across 10 years of filings, most recently posting $25000.0 for Q2 2026.

• In Q2 2026, Other Non-Current Assets changed N/A year-over-year to $25000.0; the TTM figure through Jun 2026 stood at $25000.0 (changed N/A YoY), while the FY2025 annual figure was $29000.0, changed N/A from the prior year.
• Other Non-Current Assets came in at $25000.0 for Q2 2026 at Serina Therapeutics, down from $29000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $333000.0 in Q3 2024 to a low of $24000.0 in Q3 2025.
• Average Other Non-Current Assets over 5 years is $66230.8, with a median of $50000.0 recorded in 2022.
• Year-over-year, Other Non-Current Assets surged 566.0% in 2024 and plunged 92.79% in 2025.
• Over 5 years, Other Non-Current Assets stood at $50000.0 in 2022, then changed by 0.0% to $50000.0 in 2023, then surged by 566.0% to $333000.0 in 2024, then tumbled by 91.29% to $29000.0 in 2025, then decreased by 13.79% to $25000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $25000.0 in Q2 2026, $29000.0 in Q4 2025, and $24000.0 in Q3 2025.